Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Principal Investigator: Wang, Eunice S

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Principal Investigator: Levine, Ellis G

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Principal Investigator: George, Saby

Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

Principal Investigator: Dy, Grace K

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

Principal Investigator: Fountzilas, Christos

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

Principal Investigator: Levine, Ellis G

A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

Principal Investigator: Holtan, Shernan G

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Principal Investigator: Wang, Eunice S

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Principal Investigator: Twist, Clare J

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Principal Investigator: Twist, Clare J

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

Principal Investigator: Wang, Eunice S

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Principal Investigator: Wang, Eunice S

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Principal Investigator: Fountzilas, Christos

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

Principal Investigator: Ivanick, Nathaniel M

Empathic Communication Skills (ECS) Training

Principal Investigator: Dexter, Elisabeth U

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Principal Investigator: Green, Steven D

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Principal Investigator: Kaur, Jasmeet

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Principal Investigator: Twist, Clare J

A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

Principal Investigator: Wang, Eunice S

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Principal Investigator: Wang, Eunice S

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Principal Investigator: Schofield, Grant

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

Principal Investigator: Thanikachalam, Kannan

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

Principal Investigator: Fountzilas, Christos

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Principal Investigator: Switzer, Benjamin J

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Principal Investigator: Hernandez-Ilizaliturri, Francisco J